AAAAAA

   
Results: 1-16 |
Results: 16
Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?
Authors: Visco, C Medeiros, LJ Mesina, OM Rodriguez, MA Hagemeister, FB McLaughlin, P Romaguera, JE Cabanillas, F Sarris, AH
Citation: C. Visco et al., Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?, CLIN LYMPHO, 2(1), 2001, pp. 40-46
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus
Authors: Rodriguez, J Romaguera, JE Katz, RL Said, J Cabanillas, F
Citation: J. Rodriguez et al., Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus, LEUK LYMPH, 41(1-2), 2001, pp. 185-189
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Authors: Younes, A Preti, HA Hagemeister, FB McLaughlin, P Romaguera, JE Rodriguez, MA Samuels, BI Palmer, JL Cabanillas, F
Citation: A. Younes et al., Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma, ANN ONCOL, 12(7), 2001, pp. 923-927
Primary hepatic lymphoma - Favorable outcome after combination chemotherapy
Authors: Page, RD Romaguera, JE Osborne, B Medeiros, LJ Rodriguez, J North, L Sanz-Rodriguez, C Cabanillas, F
Citation: Rd. Page et al., Primary hepatic lymphoma - Favorable outcome after combination chemotherapy, CANCER, 92(8), 2001, pp. 2023-2029
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization - A useful ancillary method for the diagnosis of mantle cell lymphoma
Authors: Katz, RL Caraway, NP Gu, J Jiang, F Pasco-Miller, LA Glassman, AB Luthra, R Hayes, KJ Romaguera, JE Cabanillas, FF Medeiros, LJ
Citation: Rl. Katz et al., Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization - A useful ancillary method for the diagnosis of mantle cell lymphoma, AM J CLIN P, 114(2), 2000, pp. 248-257
Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients
Authors: Romaguera, JE Khouri, IF Kantarjian, HM Hagemeister, FB Rodriguez, MA McLaughlin, P Sarris, AH Younes, A Rodriguez, J Cabanillas, F
Citation: Je. Romaguera et al., Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients, LEUK LYMPH, 39(1-2), 2000, pp. 77-85
Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases
Authors: Rodriguez, J Romaguera, JE Manning, J Ordonez, N Ha, C Ravandi, F Cabanillas, F
Citation: J. Rodriguez et al., Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases, LEUK LYMPH, 39(1-2), 2000, pp. 139-144
Molecular response assessed by PCR is the most important factor predictingfailure-free survival in indolent follicular lymphoma: Update of the MDACCseries
Authors: Lopez-Guillermo, A Cabanillas, F McLaughlin, P Smith, T Hagemeister, F Rodriguez, MA Romaguera, JE Younes, A Sarris, AH Preti, HA Pugh, W Lee, MS
Citation: A. Lopez-guillermo et al., Molecular response assessed by PCR is the most important factor predictingfailure-free survival in indolent follicular lymphoma: Update of the MDACCseries, ANN ONCOL, 11, 2000, pp. 137-140
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum
Authors: Nguyen, LN Ha, CS Hess, M Romaguera, JE Manning, JT Cabanillas, F Cox, JD
Citation: Ln. Nguyen et al., The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum, INT J RAD O, 47(5), 2000, pp. 1281-1285
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma
Authors: McLaughlin, P Hagemeister, FB Rodriguez, MA Sarris, AH Pate, O Younes, A Lee, MS Dang, NH Romaguera, JE Preti, AH McAda, N Cabanillas, F
Citation: P. Mclaughlin et al., Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma, SEMIN ONCOL, 27(6), 2000, pp. 37-41
Real-time 5 ' -> 3 ' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32)
Authors: Luthra, R Sarris, AH Hai, S Paladugu, AV Romaguera, JE Cabanillas, FF Medeiros, LJ
Citation: R. Luthra et al., Real-time 5 ' -> 3 ' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32), AM J CLIN P, 112(4), 1999, pp. 524-530
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma
Authors: Donato, ML Champlin, RE Van Besien, KW Korbling, M Cabanillas, F Anderlini, P Gajewski, JG Lauppe, J Durett, A Andersson, B Giralt, S Khouri, I Hagemeister, F Romaguera, JE Sarris, A McLaughlin, P Younes, A Ippoliti, C Blamble, DA Hester, J Gee, A Rodriguez, MA
Citation: Ml. Donato et al., Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma, LEUK LYMPH, 35(3-4), 1999, pp. 317-324
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/Mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination
Authors: Romaguera, JE Rodriguez, MA Hagemeister, FB McLaughlin, P Rodriguez, J Preti, A Younes, A Sarris, AH Cabanillas, F
Citation: Je. Romaguera et al., Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/Mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination, INV NEW DR, 17(2), 1999, pp. 187-192
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma
Authors: Lopez-Guillermo, A Cabanillas, F McDonnell, TI McLaughlin, P Smith, T Pugh, W Hagemeister, F Rodriguez, MA Romaguera, JE Younes, A Sarris, AH Preti, HA Lee, MS
Citation: A. Lopez-guillermo et al., Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma, BLOOD, 93(9), 1999, pp. 3081-3087
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial
Authors: Steinbach, G Ford, R Glober, G Sample, D Hagemeister, FB Lynch, PM McLaughlin, PW Rodriguez, MA Romaguera, JE Sarris, AH Younes, A Luthra, R Manning, JT Johnson, CM Lahoti, S Shen, Y Lee, JE Winn, RJ Genta, RM Graham, DY Cabanillas, FF
Citation: G. Steinbach et al., Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial, ANN INT MED, 131(2), 1999, pp. 88
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesnaand consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma
Authors: Romaguera, JE Hagemeister, FB McLaughlin, P Rodriguez, MA Bachier, C Preti, H Sarris, AH Weber, D Younes, A Cabanillas, F
Citation: Je. Romaguera et al., Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesnaand consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma, LEUK LYMPH, 32(1-2), 1998, pp. 97-106
Risultati: 1-16 |